Patent details

EP0984773 Title: PHARMACEUTICAL FORMULATION OF OMEPRAZOLE

Basic Information

Publication number:
EP0984773
PCT Application Number:
PCT/SE/98/00922
Type:
European Patent Granted for LU
Legal Status:
Surrendered
Application number:
EP989247002
PCT Publication Number:
WO/98/05380
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATION OF OMEPRAZOLE
French Title of Invention:
FORMULATION PHARMACEUTIQUE D'OMEPRAZOLE
German Title of Invention:
PHARMAZEUTISCHE OMEPRAZOL-FORMULIERUNG
SPC Number:

Dates

Filing date:
18/05/1998
Grant date:
12/03/2003
EP Publication Date:
12/03/2003
PCT Publication Date:
03/12/1998
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/03/2000
EP B1 Publication Date:
12/03/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/05/2018
Renunciation date:
21/06/2012
Revocation date:
Annulment date:

Owner

From:
18/05/1998
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
30/06/2003
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
JOSEFSSON Lars
Address:
Sweden (SE)

2

Name:
ERICKSON Magnus
Address:
Sweden (SE)

Priority

Priority Number:
9702000
Priority Date:
28/05/1997
Priority Country:
Sweden (SE)

Classification

IPC classification:
A61K 9/28; A61K 31/44;

Publication

European Patent Bulletin

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed
Filing date Document type Number of pages